Medipee | Updates

By Thomas Prokopp

Medipee applies for a market test with health insurance providers


Dear Companists,

Our goal is to find good partners early on. In order to take a further step in this direction, we have applied to participate in the Healthy Hub Initiative. This initiative gives start-ups the opportunity to test their solutions in the immediate vicinity of the statutory health insurance fund (GKV). This would be a good opportunity for us to work together with an established partner and to incorporate the knowledge gained directly into further development.

Healthy Hub

For this reason, an application was sent in to Healthy Hub’s first call this week. Healthy Hub is an initiative of five health insurance companies – BIG direkt gesund, HEK Hanseatische Krankenkasse, IKK Südwest, mhplus Betriebskrankenkasse, and SBK Siemens Betriebskrankenkasse – who came together in order to pave the way for innovative ideas in the primary health care market.  

At the start of 2018, the health insurers will help five selected startups to establish themselves on the primary health care market i.e. that of state-mandated health insurance, through a program tailored for this purpose. This will provide the startups with the opportunity of testing their solutions in the framework of statutory health insurance providers.

The initiative targets projects from the Digital-Health sector who are developing digital solutions for end-customers, and who intend to have their products reimbursed by health insurances. The program is not tied to a specific location, allowing the companies to continue working from their current headquarters.


1. Testing under real conditions

Through Healthy Hub, founders have the chance to test the market viability of their products within the real operations of a health insurance provider. This is the vision of the five insurers, who collectively insure more than three million customers.


2. Compensation of service costs           

While the tests are running, the health insurers will take on the service costs for the products. This means that participants can already start generating revenue during the testing period.


3. Evaluation 

Upon their conclusion, the test runs will be evaluated by health care experts in order to determine how effective the products worked with the insurance providers. This creates evidence and benefits. The applicants and startups can negotiate a subsequent contract if the results are positive.

4. Legal Consultation

The tests will be conducted on the basis of a suitable cooperation and contract model: The insurance providers consult the startups concerning the complex legal framework of the social security code (Sozialgesetzbuch; SGB V). They also support the startups in drafting contracts.

You can find more information here:


Countdown to our Meet and Greet next week!

Do you want to get to know the Medipee in person to ask questions and share your suggestions? On 15 December, 2017, you have the chance to meet us at the Christmas market in Moers. We will be at our pop up store at Klosterstraße 6 from 5p.m. onward. We will be happy to answer all your questions over a good glass of mulled wine and enjoy the festive atmosphere with you.


Kind regards,

Your Medipee team 


Only registered Companists can comment. Please log in to leave a comment.


Investments in startups and growth companies offer great opportunities, but they are risk investments. In the worst case, the entire investment amount may be lost. Consequently, investments in startups or growth companies are unsuitable for retirement plans. However, there is no obligation to make further contributions. Investors can minimize their risk by diversifying the amount they invest in startups and growth companies and not investing the entire amount in one startup or growth company. Professional investors often follow this strategy because it causes the risk to be distributed among several investments. In this way, successful investments can balance other less successful investments.

The shares of the investors on Companisto are subordinated profit-participating loans (partiarische Nachrangdarlehen). Such loans are shares in a business with similar characteristics as equity. If the company becomes insolvent or is liquidated, the claims of the investors (Companists) – just like those of all other shareholders of the company – will be satisfied from the assets in the insolvency or the assets in liquidation only after the claims of all other external creditors have been satisfied. Thus, Companists are treated like any other shareholder of the company during insolvency or liquidation proceedings.

The company information published on the Companisto website is provided solely by the companies. The projections made by the companies do not guarantee successful development of the company in the future. Consequently, investments in startups and growth companies are suitable only for those investors who can cope with the risk of a total loss of the capital invested. Investors make their own independent investment decisions and bear all risks themselves.

The investments are provided and issued by the individual companies. Companisto is neither the provider nor the issuer of the investments, but solely the internet service platform.

€ 174,200


€ 601

Average Investment

12.28 %

Share Offered

Please note
The acquisition of the offered securities and investments is associated with considerable risks and can lead to the complete loss of the invested assets. The expected yield is not guaranteed and may be lower. Whether it is a security or an asset investment can be seen in the description of the investment opportunity.
Contact Us
If you have any questions about investing on Companisto, please contact our service team:

Toll-free phone number for investors calling from Germany:
0800 - 100 267 0

Companisto investors hotline:
+49(0)30 - 346 491 493

We are available Monday through Friday between 9 a.m. – 6 p.m.

For companies
Apply for financing Investment Model FAQ for Companies
Investor Support
Please register in order to see the complete profile of Medipee.
Already registered?    Log in